{"text": "bmy lian bristol myers lianbio s heart drug camzyos gets priority review in china"}
{"text": "mrk bmy lly earnings next week"}
{"text": "the following bp are reporting next week i ll will not be surprised if they slip in a bo to shift attention from their current patent cliffs and loss of revenues the next few years 4 26 gsk 4 27 abbv bmy gild"}
{"text": "attractive call overwrites vz calls more expensive than 100 of history pfe 100 uso 100 bmy 100 vxx 100 on 100 wdc 100"}
{"text": "lian licensed rights from myokardia now a wholly owned subsidiary of bmy in august 2020 for the development and commercialization of mavacamten in mainland china hong kong macau taiwan thailand and singapore"}
{"text": "companies with important clinical readouts coming soon bmy trotabresib bet inhibitor by bristol myers squibb in p1 nct03220347"}
